Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria

Diabetes

Volumn 47, Issue 8, 1998, Pages 1347-1353

  Trevisan, Roberto ^a,b   Bruttomesso, Daniela ^a   Vedovato, Monica ^a   Brocco, Stefano ^a   Pianta, Alessandro ^a   Mazzon, Cinzia ^a   Girardi, Carlo ^a   Jori, Elisabetta ^a   Semplicini, Andrea ^a   Tiengo, Antonio ^a   Prato, Stefano Del ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Dipartimento di Medicina Clinica e Sperimentale   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; INSULIN; POTASSIUM ION; SODIUM ION;

ADULT; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL REACTIVITY; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETOGENESIS; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; KALIURESIS; KIDNEY BLOOD FLOW; KIDNEY PLASMA FLOW; MALE; MICROALBUMINURIA; NATRIURESIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM INTAKE;

ADRENAL GLANDS; ADULT; ALBUMINURIA; ANGIOTENSIN II; BLOOD PRESSURE; BODY WEIGHT; DIABETES MELLITUS, TYPE 1; DIET; DIET, SODIUM-RESTRICTED; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; NATRIURESIS; POTASSIUM; RENAL CIRCULATION; SODIUM;

EID: 0031847985     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.8.1347     Document Type: Article

References (47)

1. Messent JWC, Elliott TG, Hill RD, Jarrett RJ, Keen H, Viberti GC: Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three-year follow-up study. Kidney Int 41:836-839, 1992
2. Earle KA, Mishra M, Morocutti A, Barnes D, Stephens E, Chambers J, Viberti GC: Microalbuminuria as a marker of silent myocardial ischaemia in IDDM patients. Diabetologia 39:854-856, 1996
3. Yip J, Mattock MB, Morocutti A, Sethi M, Trevisan R, Viberti GC: Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet 342:883-887, 1993
4. Trevisan R, Nosadini R, Fioretto P, Semplicini A, Donadon V, Doria A, Nicolosi G, Zanuttini D, Cipollina MR, Lusiani L, Avogaro A, Crepaldi G, Viberti GC: Clustering of risk factors in hypertensive insulin-dependent diabetics with high sodium-lithium countertransport. Kidney Int 41:855-862, 1992
5. Feldt-Rasmussen B, Mathiesen ER, Deckert T, Giese J, Christensen NJ, Bent-Hansen L, Nielsen MD: Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone, and cate-cholamines in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30:610-617, 1987
6. De Chatel R, Weidmann P, Flammer J, Ziegler WH, Beretta-Piccoli C, Vetter W, Reubi FC: Sodium, renin, aldosterone, catecholamines, and blood pressure in diabetes mellitus. Kidney Int 12:412-421, 1977
7. De Fronzo RA: The effect of insulin on renal sodium metabolism: a review with clinical implications. Diabetologia 21:165-171, 1981
8. Skott P, Hother-Nielsen O, Bruun NE, Giese J, Nielsen MD, Beck-Nielsen H, Parving HH: Effects of insulin on kidney function and sodium excretion in healthy subjects. Diabetologia 32:694-699, 1989
9. Trevisan R, Fioretto P, Mozzato MG, Donadon V, Zanette G, Mantero F, Opocher G, Remuzzi G, Benigni A, Giorato C, Nosadini R: Role of insulin and atrial natriuretic peptide in sodium retention in insulin-treated IDDM patients during isotonic volume expansion. Diabetes 39:289-298, 1990
10. Weinberger MH: Salt sensitivity of blood pressure in humans. Hypertension 27 (part 2):481-490, 1996
11. Williams GH, Hollenberg NK: Are non-modulating patients with essential hypertension a distinct subgroup? Implications for therapy. Am J Med 79 (Suppl. 3C):3-9, 1985
12. Hollenberg NK, Moore T, Shoback D, Redgrave J, Rabinowe S, Williams GH: Abnormal renal sodium handling in essential hypertension: relation to failure of renal and adrenal modulation of responses to angiotensin II. Am J Med 81:412-418, 1986
13. Shoback DM, Williams GH, Moore TJ, Dluhy RG, Podolsky S, Hollenberg NK: Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension. J Clin Invest 72:2115-2124, 1983
14. Sharma AM, Ruland KR, Spies KP, Distler A: Salt sensitivity in young nor-motensive subjects is associated with a hyperinsulinemic response to oral glucose. J Hypertens 9:329-335, 1991
15. Zavaroni I, Coruzzi P, Bonini L, Mossini GL, Musiari L, Gasparini P, Fantuzzi M, Reaven GM: Association between salt sensitivity and insulin concentrations in patients with hypertension. Am J Hypertens 8:855-858, 1995
16. Sharma AM, Schorr U, Distler A: Insulin resistance in young salt-sensitive normotensive subjects. Hypertension 21:273-279, 1993
17. Strojek K, Greszczak W, Lacka B, Gorska J, Keller CK, Ritz E: Increased prevalence of salt sensitivity of blood pressure in IDDM with and without microalbuminuria. Diabetologia 38:1443-1448, 1995
18. National High Pressure Education Program: Working group report on primary prevention on hypertension. Arch Intern Med 153:186-202, 1993
19. De Fronzo R, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
20. Schurr E, Lahme W, Kuppers H: Measurement of renal clearance of insulin and PAH in the steady state without urine collection. Clin Nephrol 12:26-29, 1980
21. Cole RA, Soeldner JS, Dunn PJ, Bunn HF: A rapid method for the determination of glycosylated hemoglobins using high-pressure liquid chromatography. Metabolism 27:289-301, 1978
22. Weinberger MH, Miller JZ, Luft FC, Grim CE, Fimberg NS: Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 8 (Suppl. II): 127-134, 1986
23. Rocchini AP: The relationship of sodium sensitivity to insulin resistance. Am J Med Sci 307 (Suppl. 1):75-80, 1994
24. Bigazzi R, Bianchi S, Baldari D, Sgherri G, Baldari G, Campese VM: Microalbuminuria in salt-sensitive patients: a marker for renal and cardiovascular risk factors. Hypertension 23:195-199, 1994
25. Bianchi S, Bigazzi R, Galvan AQ, Muscelli E, Baldari G, Pecori N, Ciociaro D, Ferrannini E, Natali A: Insulin resistance in microalbuminuric hypertension: sites and mechanisms. Hypertension 26:789-795, 1995
26. Weir MR, Dengel DR, Behrens MT, Goldberg AP: Salt-induced increases in systolic blood pressure affect renal hemodynamics and proteinuria. Hypertension 25:1339-1344, 1995
27. Gavras H: How does salt raise blood pressure? A hypothesis. Hypertension 8:83-88, 1986
28. The Microalbuminuria Captopril Study Group: Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. Diabetologia 39:587-593, 1996
29. Mathiesen ER, Gall MA, Hommel E, Skott P, Parving HH: Effects of short-term strict metabolic control on kidney function and extracellular fluid volume in incipient diabetic nephropathy. Diabet Med 6:595-600, 1989
30. Sechi LA, Griffin CA, Grady EF, Kalinyak JE, Schambelan M: Insulin receptor concentration and gene expression are modulated by sodium intake in the rat kidney. J Hypertens 9:5212-5213, 1991
31. Chen PY, Sanders PW: L-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest 88:1559-1567, 1991
32. Balon TW, Nadler JL: Evidence that nitric oxide increases glucose transport in skeletal muscle. J Appl Physiol 82:359-363, 1997
33. Donovan DS, Solomon CG, Seely EW, Williams GH, Simonson DC: Effect of sodium on insulin sensitivity. Am J Physiol 264:E730-E734, 1993
34. Dengel DR, Goldberg AP, Maynga RS, Kairis GM, Weir MR: Insulin resistance, elevated glomerular filtration fraction, and renal injury. Hypertension 28:127-132, 1996
35. Gaboury CL, Simonson DC, Seely EW, Hollenberg NK, Williams GH: Relation of pressor responsiveness to angiotensin II and insulin resistance in hypertension. J Clin Invest 94:2295-2300, 1994
36. Hostetter TH, Rennke HG, Brenner NM: The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 72:375-380, 1982
37. Baron AD, Brechtel G: Insulin differentially regulates systemic and skeletal muscle vascular resistance. Am J Physiol 265:E61-E67, 1993
38. Feldman RD, Bierbrier GS: Insulin-mediated vasodilation: impairment with increased blood pressure and body mass. Lancet 342:707-709, 1993
39. Elliott TG, Cockcroft JR, Groop PLT, Viberti GC, Ritter JM: Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci (Colch) 85:687-693, 1993
40. Folli F, Kahn CR, Hansen H, Bouchie JL, Feener EP: Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. J Clin Invest 100:2158-2169, 1997
41. Ferrari P, Travaglini M, Schild C, Allemann Y, Shaw S, Weidmann P: Enhanced blood pressure response to mineral corticoid stimulation in normotensive members of hypertensive families. Blood Pressure 1:86-91, 1992
42. Weinberger MH, Miller JZ, Grim CE, Luft FC, Fineberg NS, Christian JC: Sodium sensitivity and resistance of blood pressure are associated with different haptoglobin phenotypes. Hypertension 10:443-446, 1987
43. Krolewski AS, Canessa M, Warram JH, Laffel LMB, Christlieb AR, Knowler WC, Rand LI: Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes. N Engl J Med 318:140-145, 1988
44. Trevisan R, Li LK, Messent J, Triq T, Earle KA, Walker JD, Viberti GC: Sodium-hydrogen antiport activity and cell growth in cultured skin fibroblasts of IDDM patients with nephropathy. Diabetes 41:1239-1246, 1992
45. Yip J, Mattock M, Sethi M, Morocutti A, Viberti GC: Insulin resistance in family members of insulin-dependent diabetic patients with microalbuminuria. Lancet 341:369-370, 1993
46. Allen TJ, Walbron MJ, Casley D, Jerums G, Cooper ME: Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes. Diabetes 46:119-124, 1997
47. Redgrave J, Rabinowe S, Hollenberg NK, Williams GH: Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives. J Clin Invest 75:1285-1290, 1985